loadpatents
Patent applications and USPTO patent grants for LUO; Tianci.The latest application filed is for "enveloped virus resistant to complement inactivation for the treatment of cancer".
Patent | Date |
---|---|
Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer App 20220169701 - LUO; Tianci ;   et al. | 2022-06-02 |
Enveloped virus resistant to complement inactivation for the treatment of cancer Grant 11,274,141 - Luo , et al. March 15, 2 | 2022-03-15 |
Fusion Protein Between Short Form Rod-Derived Cone Viability Factor and a Hydrophilic Peptide App 20210162005 - LUO; Tianci ;   et al. | 2021-06-03 |
Complement factor B analogs and their uses Grant 11,001,822 - Chen , et al. May 11, 2 | 2021-05-11 |
Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide Grant 10,946,063 - Luo , et al. March 16, 2 | 2021-03-16 |
Complement Factor B Analogs and Their Uses App 20200325464 - CHEN; ChangHung ;   et al. | 2020-10-15 |
Complement factor B analogs and their uses Grant 10,689,637 - Chen , et al. | 2020-06-23 |
Complement Factor B Analogs and Their Uses App 20190338268 - CHEN; ChangHung ;   et al. | 2019-11-07 |
Complement factor B analogs and their uses Grant 10,415,026 - Chen , et al. Sept | 2019-09-17 |
Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer App 20190194292 - LUO; Tianci ;   et al. | 2019-06-27 |
Fusion Protein Between Short Form Rod-Derived Cone Viability Factor and a Hydrophilic Peptide App 20190151410 - LUO; Tianci ;   et al. | 2019-05-23 |
Vectors encoding rod-derived cone viability factor Grant 10,040,835 - Luo August 7, 2 | 2018-08-07 |
Complement Factor B Analogs and Their Uses App 20170037391 - CHEN; ChangHung ;   et al. | 2017-02-09 |
Complement factor B analogs and their uses Grant 9,533,028 - Chen , et al. January 3, 2 | 2017-01-03 |
Vectors Encoding Rod-derived Cone Viability Factor App 20160108099 - LUO; Tianci | 2016-04-21 |
Complement Factor B Analogs And Their Uses App 20160082091 - CHEN; ChangHung ;   et al. | 2016-03-24 |
Vectors encoding rod-derived cone viability factor Grant 9,265,813 - Luo February 23, 2 | 2016-02-23 |
Method for treating ocular neovascularization Grant 9,238,057 - Brazzell , et al. January 19, 2 | 2016-01-19 |
Complement factor B analogs and their uses Grant 9,228,003 - Chen , et al. January 5, 2 | 2016-01-05 |
Vectors Encoding Rod-derived Cone Viability Factor App 20140328821 - Luo; Tianci | 2014-11-06 |
Complement Factor B Analogs And Their Uses App 20140249072 - Chen; ChangHung ;   et al. | 2014-09-04 |
Method for Treating Ocular Neovascularization App 20130165503 - BRAZZELL; Romulus Kimbro ;   et al. | 2013-06-27 |
Method for treating ocular neovascularization Grant 8,338,384 - Brazzell , et al. December 25, 2 | 2012-12-25 |
Bovine immunodeficiency virus (BIV) based vectors Grant 8,236,558 - Luo , et al. August 7, 2 | 2012-08-07 |
Lentiviral packaging constructs Grant 8,183,356 - Kaleko , et al. May 22, 2 | 2012-05-22 |
Bovine Immunodeficiency Virus (BIV) Based Vectors App 20110171733 - Luo; Tianci ;   et al. | 2011-07-14 |
Method for treating ocular neovascularization App 20100286253 - Brazzell; Romulus Kimbro ;   et al. | 2010-11-11 |
Bovine immunodeficiency virus (BIV) based vectors Grant 7,785,877 - Luo , et al. August 31, 2 | 2010-08-31 |
Treatment Of Diseases Characterized By Inflammation App 20100120665 - Kaleko; Michael ;   et al. | 2010-05-13 |
Lentiviral packaging constructs Grant 7,700,342 - Kaleko , et al. April 20, 2 | 2010-04-20 |
Bovine immunodeficiency virus (BIV) based vectors Grant 7,662,621 - Luo , et al. February 16, 2 | 2010-02-16 |
Bovine immunodeficiency virus (BIV) based vectors App 20090093040 - Luo; Tianci ;   et al. | 2009-04-09 |
Lentiviral Packaging Constructs App 20080268522 - Kaleko; Michael ;   et al. | 2008-10-30 |
Lentiviral packaging constructs Grant 7,442,551 - Kaleko , et al. October 28, 2 | 2008-10-28 |
Lentiviral Packaging Constructs App 20080021207 - Kaleko; Michael ;   et al. | 2008-01-24 |
Bovine Immunodeficiency Virus (biv) Based Vectors App 20070207546 - Luo; Tianci ;   et al. | 2007-09-06 |
Bovine immunodeficiency virus (BIV) based vectors Grant 7,202,079 - Luo , et al. April 10, 2 | 2007-04-10 |
Bovine immunodeficiency virus (BIV) based vectors Grant 7,198,793 - Luo , et al. April 3, 2 | 2007-04-03 |
Lentiviral Packaging Constructs App 20070010017 - Kaleko; Michael ;   et al. | 2007-01-11 |
Bovine immunodeficiency virus (BIV) based vectors Grant 7,153,512 - Luo , et al. December 26, 2 | 2006-12-26 |
Bovine immunodeficiency virus (BIV) based vectors Grant 7,125,712 - Luo , et al. October 24, 2 | 2006-10-24 |
Lentiviral packaging constructs Grant 7,070,993 - Kaleko , et al. July 4, 2 | 2006-07-04 |
Bovine immunodeficiency virus (BIV) based vectors App 20060019394 - Luo; Tianci ;   et al. | 2006-01-26 |
Bovine immunodeficiency virus (BIV) based vectors App 20050208660 - Luo, Tianci ;   et al. | 2005-09-22 |
Recombinant bovine immunodeficiency virus based gene transfer system App 20050191747 - Luo, Tianci ;   et al. | 2005-09-01 |
Bovine immunodeficiency virus (BIV) based vectors App 20050148078 - Luo, Tianci ;   et al. | 2005-07-07 |
Bovine immunodeficiency virus (BIV) based vectors App 20050148077 - Luo, Tianci ;   et al. | 2005-07-07 |
Bovine immunodeficiency virus (BIV) based vectors Grant 6,864,085 - Luo , et al. March 8, 2 | 2005-03-08 |
Lentiviral packaging constructs App 20030054548 - Kaleko, Michael ;   et al. | 2003-03-20 |
Bovine immunodeficiency virus (BIV) based vectors App 20020098475 - Luo, Tianci ;   et al. | 2002-07-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.